Streetbeat News

Earnings

SHEL

Shell (NYSE:SHEL) reported Q3 2024 earnings of $1.92 per share, surpassing the $1.66 estimate, and sales of $71.089 billion, exceeding the $61.343 billion estimate. Despite beating estimates, sales decreased by 6.89% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 7:10 am

META

Meta Platforms (NASDAQ:META) experienced a 3.18% decline in after-hours trading despite strong Q3 results and a raised price target of $650 by analyst Zev Fima. The company exceeded revenue and earnings expectations, highlighting its growth in AI and cost control. Fima suggests long-term benefits for investors.

Portfolio Pulse from Pooja Rajkumari

October 31, 2024 | 7:04 am

ASX

ASE Tech Holding Co reported Q3 2024 earnings per share of $0.13, missing the analyst estimate of $0.15. Sales were $4.960 billion, below the expected $5.146 billion. Despite the miss, earnings increased by 5.51% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 7:00 am

MU

NVDA

Samsung Electronics reported strong profits for the September quarter, but delays in NVIDIA's AI chip certification have allowed SK Hynix and Micron Technology to take the lead in high-bandwidth memory. Samsung's chip division earned $2.8 billion, while SK Hynix posted a record profit.

Portfolio Pulse from Kaustubh Bagalkote

October 31, 2024 | 6:57 am

TAK

Takeda has raised its FY2024 outlook, expecting higher revenue and core EPS due to milder generic erosion of VYVANSE and strong business momentum. The company now forecasts revenue of ¥4.48 trillion and core EPS of ¥456, with adjusted free cash flow between ¥400 billion and ¥500 billion.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:50 am

BUD

Anheuser-Busch InBev has raised its 2024 EBITDA growth outlook to 6%-8% from the previous 4%-8% and expects capital expenditure to be between $4B-$4.5B. The company also provided guidance on net finance costs, effective tax rates, and net capital expenditure for FY24.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:42 am

STM

STMicroelectronics has provided its fiscal 2024 revenue outlook, expecting $13.27 billion, slightly below the consensus of $13.366 billion. The company also anticipates a slightly lower gross margin year-over-year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:34 am

STM

STMicroelectronics has provided guidance for Q4 2024, expecting net revenues of $3.32 billion, slightly below the consensus of $3.396 billion. The company anticipates a gross margin of 38%, with a potential variance of 200 basis points.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:28 am

TAK

Takeda Pharmaceutical reported a significant increase in Q2 2024 earnings and sales, with EPS rising by 20.72% year-over-year and sales surpassing analyst estimates by 8.48%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:23 am

ARGX

argenx reported Q3 2024 earnings of $1.39 per share, significantly surpassing the analyst estimate of $0.02. Sales reached $588.878 million, exceeding expectations and marking a 73.28% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2024 | 6:11 am